A Phase 2a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Bronchial Allergen Challenge Study to Assess the Safety, Tolerability, and Efficacy of Inhaled AIR645 in Subjects With Mild Allergic Asthma.
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2010
At a glance
- Drugs AIR 645 (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 21 Jul 2010 Actual end date (June 2010) added as reported by ClinicalTrials.gov.
- 21 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Oct 2009 Actual initiation date (1 Oct 2009) added as reported by ClinicalTrials.gov.